Gregory G. Freitag
Mr. Freitag, J.D., CPA, joined AxoGen in June 2010. He was appointed interim CFO in August 2015 to serve until his replacement is hired. He has served as General Counsel, Senior Vice President of Business Development and a Member of the Board of Directors for AxoGen, Inc. since May 2014. Prior to his current role, Greg served as Chief Financial Officer of AxoGen, Inc. and a Member of its Board of Directors from June 2010 to May 2014. From June 30, 2010 to September 2011 Gregory was Chief Executive Officer of LecTec Corporation, having resigned such position pursuant to the reverse merger between LecTec Corporation (renamed AxoGen Inc.) and AxoGen Corporation, AxoGen, Inc.'s wholly owned subsidiary. Since May 2009, Greg has been a principal of FreiMc, LLC, a consulting and advisory firm that provides strategic guidance and business development advisory services related to the life sciences and healthcare markets. Prior to founding FreiMc, LLC Greg was the Director of Business Development at Pfizer Health Solutions, a former subsidiary of Pfizer, Inc., from January 2006 to May 2009. From July 2005 to January 2006, Greg worked for Guidant Corporation in their business development group. Prior to Guidant Corporation, Greg was the Chief Executive Officer of HTS Biosystems, a biotechnology tools start-up company, from March 2000 until its sale in early 2005. Greg was the Chief Operating Officer, Chief Financial Officer and General Counsel of Quantech, Ltd., a public point of care diagnostic company, from December 1995 to March 2000. Prior to that time, Greg practiced corporate/securities law in Minneapolis, Minnesota. Greg is also a director of the Foundation Board of HealthEast Care System, a health care system in Minnesota.